78784-70-0

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-6-(2-pyridinylmethyl)pyridazine is used as an antipsychotic and antidepressant medication for the treatment of psychiatric disorders such as schizophrenia and bipolar disorder. Its unique pharmacological profile, which includes dopamine receptor partial agonism and serotonin receptor agonist and antagonist activity, contributes to its efficacy in managing these conditions.
Used in Research and Development:
3-Chloro-6-(2-pyridinylmethyl)pyridazine is used in research and development for the study of its potential therapeutic uses and mechanism of action. Further investigation is needed to fully understand its role in treating various psychiatric disorders and to explore additional applications in the field of mental health.

InChI:InChI=1/C10H8ClN3/c11-10-5-4-9(13-14-10)7-8-3-1-2-6-12-8/h1-6H,7H2

Upstream product

• 109-04-6 2-bromo-pyridine 
• 135034-10-5 3-chloro-6-iodopyridazine 
• 160427-24-7 4-Hydroxy-6-pyridin-2-yl-4,5-dihydro-2H-pyridazin-3-one 
• 1005036-22-5 potassium 2-hydroxy-4-oxo-4-(pyridin-2-yl)butanoate 
• 1122-62-9 2-acetylpyridine 
• 66317-38-2 6-(pyridine-2-yl)-2,3-dihydropyridazin-3-one 

Downstream Products

• 479628-50-7 3-(pyridin-2-yl)pyridazine 
• 1005035-89-1 6-(pyridin-2-yl)-3-(tributylstannyl)-pyridazine 
• 1005035-91-5 C₁₃H₁₅N₃ 
• 1177267-50-3 (trans)-8-({[6-(2-fluorophenyl)-3-pyridazinyl]amino}methyl)-3-(2-fluoro-3-pyridinyl)-1-oxa-3-azaspiro[4.5]decan-2-one 

Relevant academic research and scientific papers

Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses

The present invention relates to nonlinear oligopyridazine compounds, to processes for obtaining them, to their uses, and also to their reduction to oligopyrroles and to the uses of the pyridazinylpyrrole and oligopyrrole compounds obtained. The invention relates in particular to the uses as medicaments, in particular for treating pathologies such as cancer, bacterial infections or parasitic infections, and also the uses in the materials, environmental, electronics and optics field.

LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS

The present invention relates to linear pyridazine compounds, and more particularly to those of these compounds which are oligopyridazine compounds, to processes for obtaining them, to their uses, and also to their reduction to pyrroles and to the uses of the pyrrole, pyridazinylpyrrole and oligopyrrole compounds obtained. The invention relates in particular to the uses as medicaments, in particular for treating pathologies such as cancer, bacterial infections or parasitic infections, and also the applications in the materials, environmental, electronics and optics field.

HETEROCYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where x, y, G, J, K, L, M, V R2, R3, R4, R5, R5a, R6, R6a, R7, R7a, R8 and R8a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines

This disclosure describes novel 6- and 8-heteroaryl and substituted 6- and 8-heteroaryl-1,2,4-triazolo[4,3-b]-pyridazines and their use as agents for treating anxiety.